Live Breaking News & Updates on Curis Anti Infective Cures

Stay updated with breaking news from Curis anti infective cures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-News: AiCuris' Licensing Partner MSD Demonstrates Efficacy in Phase 3 Study with PREVYMIS for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation

24.10.2022 - EQS-News: AiCuris Anti-infective Cures AG / Key word(s): Study results AiCuris’ Licensing Partner MSD Demonstrates Efficacy in Phase 3 Study with PREVYMIS for Prevention of Cytomegalovirus Disease in Adults After Kidney Transplantation 24.10.2022 . ....

United States , Nordrhein Westfalen , Katja Woestenhemke , Holger Zimmermann , Merck Co Inc , Mc Services , Drug Administration , Distribution Services , Curis Anti Infective Cures , Annual Meeting , Aicuris Anti Infective Cures , Corporate News , Regulatory Announcements , Eqs News ,

AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022

08.04.2022 AiCuris nominates Madam Therapeutics with its innovative peptide approach to fight AMR as the first winner of the AiCubator Resident Status in 2022 | AiCuris Anti-infective Cures AG | News | Nachricht | Mitteilung ....

Nordrhein Westfalen , Remko Van Leeuwen , Lysando Artilysin , Holger Zimmermann , Aicuris Aicubator , Madam Therapeutics , Aicubator Resident Status , Curis Anti Infective Cures , Aicuris Anti Infective Cures , German Future Prize , German President , Immune System , Life Saving Innovation , D Hoc ,

AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus

09.02.2022 AiCuris and Hybridize Therapeutics enter worldwide license agreement of up to €100M for a direct-acting RNA-based therapy against BK Virus | AiCuris Anti-infective Cures AG | News | Nachricht | Mitteilung ....

United States , Nordrhein Westfalen , Holger Zimmermann , Leiden University Medical Center , Department Of Nephrology , Hybridize Therapeutics , Curis Anti Infective Cures , Antisense Oligonucleotide , D Hoc ,

PRESS RELEASE : AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections

A new class of molecules with a novel resistance-breaking mode of action and the potential to replace common antibiotics Artilysins are able to pass the protective outer membrane of Gram-negative. ....

Krung Thep Mahanakhon , Nordrhein Westfalen , United States , Lysando Gmb , Lysando Artilysin , Markus Graf Matuschka , Holger Zimmermann , Alliance Aicuris , Aicuris Anti Infective Cures , Curis Anti Infective Cures , Lysando Gmbh , Chronic Wounds , Diabetic Foot Infections , About Lysando , German Future Prize , German President , Immune System , Life Saving Innovation , Dow Jones ,